FRom Utah.gov:
“Novel COVID-19 monoclonal antibody therapy
Due to increased incidence of variant forms of SARS-CoV-2 which have greater resistance to monoclonal antibody monotherapies, as of March 23, 2021, it is now recommended that Utah providers exclusively use combination monoclonal antibody therapies.”
....
Are these “combination MAT’s” good?
Regeneron is a combo therapy — early on single therapy was good (bamlanivimab) then they added a second monoclonal to it — but Regeneron is a combination therapy ... and it WORKS. QUICKLY.